Fresenius Vamed - A Polyclinic in Ghana
Fresenius Vamed is a leading global provider of services for hospitals and other healthcare facilities. Its portfolio ranges from project development and planning to the total operational management of healthcare facilities and providing services to patients. The services are aimed at various areas of healthcare, ranging from prevention to acute care, rehabilitation, and nursing.
Headquartered in Vienna, Austria, Fresenius Vamed has successfully completed more than 1,000 healthcare projects in 101 countries on five continents since the company’s founding in 1982.
VAMED Value Chain
- Project development
- Project management and construction
- Services (technical, commercial, infrastructural)
- Operational management (technical Management, total operational management)
The project business comprises the consulting, project development, planning, turnkey construction, and financing management of projects. VAMED responds flexibly to the local needs of clients, providing custom-tailored solutions all from one source. The company also carries out projects in cooperation with partners. Among public clients there is growing interest in public-private partnership (PPP) models. With 25 of these models, VAMED is a pioneer in this market segment.
VAMED offers a full range of facility management services for healthcare facilities. Modular in design, the company's service offering encompasses every aspect of technical, commercial, and infrastructural facility management. This ranges from building and equipment maintenance, medical technology management, and technical management through to the operational management. Its integrated portfolio of services is aimed at the optimal operation of a healthcare facility. VAMED was responsible for the total operational management of about 100 healthcare facilities on five continents with more about 18,000 beds. Worldwide, VAMED provides technical operation services to more than 840 hospitals with about 227,000 beds.
Vamed belongs to Fresenius SE & Co. KGaA healthcare group with a stake of about 77 percent and is one of the two Investment Companies of Fresenius.
Key figures (IFRS)
|€ in millions||2022||2021||Growth|
|2,359||2,297||+ 2 %|
|20||101||- 81 %|
|0.8 %||4.4 %|
|96||81||+ 19 %|
|1,241||1,290||- 4 %|
Employees (December 31)
|20,184||19,721||+ 2 %|
Some figures adjusted for special items
Net income = Net income attributable to shareholders of Fresenius Medical Care